Poseida Therapeutics Inc. buy BiotechBee
Start price
10.12.23
/
50%
€2.98
Target price
31.05.25
€4.00
Performance (%)
-1.21%
Price
17.05.24
€2.94
Summary
This prediction is currently active. With a performance of -1.21%, the BUY prediction for Poseida Therapeutics Inc. by BiotechBee is down slightly. This prediction currently runs until 31.05.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Poseida Therapeutics Inc. | - | - |
iShares Core DAX® | -0.268% | 5.471% |
iShares Nasdaq 100 | 1.854% | 7.851% |
iShares Nikkei 225® | 0.284% | 1.729% |
iShares S&P 500 | 1.178% | 5.269% |
According to BiotechBee what are the pros and cons of Poseida Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Poseida Therapeutics Inc. diskutieren
Buy mit Kursziel 4,0